SCHEMBL23155370

SCHEMBL23155370

c1ccc(N(c2ccc3c(c2)-c2c4cccc2-c2cccc-3c2-c2ccccc2-4)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ AHR P35869 2/20 0.36
▸ ALOX5 P09917 2/20 0.35
▸ LMNA P02545 2/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ PGR P06401 1/20 0.32
▸ NTRK1 P04629 1/20 0.32
▸ PLK3 Q9H4B4 1/20 0.32
▸ KEAP1 Q14145 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155330 0.94 NPC1 (0.36) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155124 0.93 NPC1 (0.35) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155362 0.92 AHR (0.39) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155311 0.90 PLA2G2A (0.37) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155245 0.89 ALDH1A1 (0.36) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155228 0.87 NPC1 (0.35) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155354 0.86 MEN1 (0.37) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL25580698 0.86 NPC1 (0.38) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155167 0.85 MAPT (0.35) MAPTNPC1KDM4EMEN1ALDH1A1
SCHEMBL23155122 0.85 MMP12 (0.35) MAPTNPC1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
EP-3799144-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-06-01 — — EP disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed
EP-3799144-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2021-03-31 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 MAPT 4116/4885NPC1 2344/4885KDM4E 2359/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 MAPT 4116/4885NPC1 2344/4885KDM4E 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback